Search clinical trials for: cytokine-induced killer cell

Total 589 results

Alliancells-PuRui Biocience Co., Ltd.
Zhongyuan Union Stem Cell Bio-engineering Corporation

Unknown

Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

Renal Cell Carcinoma | Hepatocellular Carcinoma | Lung Cancer

China
Siriraj Hospital
Mahidol University

Unknown

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells

Cholangiocarcinoma

Thailand
Robert Negrin
National Institutes of Health (NIH)

Unknown

Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation

Multiple Myeloma | Blood and Marrow Transplant (BMT)

United States
The First People's Hospital of Changzhou

Active, not recruiting

CIK in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms
The First People's Hospital of Changzhou

Not yet recruiting

CIK in Treating Patients With Esophageal Cancer

Esophageal Squamous Cell Carcinoma
Yanjuan Zhu

Unknown

Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer (CIKCC)

Colonic Neoplasms

China
People's Hospital of Guangxi

Unknown

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer

Small Cell Lung Cancer

China
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Ovarian Carcinoma
Xiaoyi Huang

Unknown

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Renal Cell Carcinoma | Nasopharyngeal Carcinoma | Colorectal Cancer | Lung Cancer

China
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Cholangiocarcinoma

China
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

Cervical Cancer
Guangxi Medical University

Unknown

Study of DC-CIK to Treat Colorectal Cancer

Colorectal Cancer

China
Guangxi Medical University

Unknown

Study of DC-CIK to Treat NPC

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

CIK Treatment for HCC Patient Underwent Radical Resection

Carcinoma, Hepatocellular

China
The First People's Hospital of Changzhou

Active, not recruiting

The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer

Colorectal Neoplasms
Sun Yat-sen University

Completed

Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer (HCC-CIK)

Hepatocellular Carcinoma

China
Institute of Biophysics and Cell Engineering of...
Belarusian State Medical University

Not yet recruiting

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Bladder Cancer | Renal Cancer

Belarus
Affiliated Hospital to Academy of Military Medical...

Unknown

Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases

Non-Small-Cell Lung Cancer With Bone Metastases

China
Chinese PLA General Hospital

Completed

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Dana-Farber Cancer Institute
ImmunityBio, Inc.

Not yet recruiting

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

Ovarian Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Recurrent Ovary Cancer | Ovarian Carcinoma, Recurrent

United States
The First People's Hospital of Changzhou

Completed

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Colorectal Cancer

China
Sun Yat-sen University

Unknown

Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy

Stage III Colon Cancer

China
Guangxi Medical University

Unknown

A Study of DC-CIK to Treat Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

China
The First People's Hospital of Changzhou

Not yet recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin
Sabz Biomedicals
Ministry of Health and Medical Education; Digestive Diseases Research Institute...

Recruiting

Autologous Killer Cell Therapy in Colon Cancer Patients

Colon Cancer Stage IV

Iran, Islamic Republic of
Henan Cancer Hospital
Henan Provincial People's Hospital; Hebei Medical University Fourth Hospital; Tangshan People's Hospital and other collaborators

Terminated

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

Lung Adenocarcinoma

China
Brenda Cooper, MD

Completed

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

Soft Tissue Sarcoma | Acute Myeloid Leukemia | Hodgkin Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Plasma Cell Myeloma | Rhabdomyosarcoma | Colon Carcinoma | Adenocarcinoma of Rectum | Myeloproliferative Syndromes and other conditions

United States
Dana-Farber Cancer Institute
ImmunityBio, Inc.; Kidney Cancer Association

Not yet recruiting

Memory-like Natural Killer (NK) Cell Therapy With N-803 in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Renal Cell Carcinoma | Urothelial Carcinoma | Renal Carcinoma

United States
A.O. Ospedale Papa Giovanni XXIII
Regional Hospital of Bolzano; Azienda Ospedaliera San Gerardo di Monza

Completed

Cytokine Induced Killer (CIK) Cells In Leukemia Patients (CIK2)

Hematologic Malignancies

Italy
Beijing Biohealthcare Biotechnology Co.,Ltd

Unknown

DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment

Gastric Cancer

China
University of Malaya

Recruiting

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Advanced Solid Tumor | Pancreatic Ductal Adenocarcinoma

Malaysia
Han weidong

Unknown

Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas (CIK)

B Cell Lymphoma | Solid Tumors

China
The First People's Hospital of Changzhou

Not yet recruiting

Cytokine-induced Killer Study for Patients With Stage II Melanoma

Melanoma
The First People's Hospital of Changzhou

Active, not recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

Stomach Neoplasms
The First People's Hospital of Changzhou

Active, not recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR

Adenocarcinoma of Lung
Tianjin Medical University Cancer Institute and...

Unknown

Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma

China
Henan Cancer Hospital

Terminated

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

Advanced Cancer

China
People's Hospital of Guangxi

Unknown

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
FDA Office of Orphan Products Development

Completed

Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine

Guillain-Barre Syndrome

United States
Kunming Medical University

Terminated

CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

China
Southwest Hospital, China

Unknown

By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy

Hepatocellular Carcinoma

China
Washington University School of Medicine
Melanoma Research Alliance; Rising Tide Foundation

Not yet recruiting

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

Metastatic Melanoma | Advanced Melanoma

United States
Wenxiang Wang
Shanghai Houchao Biotechnology Co., Ltd

Unknown

Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Completed

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer (CIK)

Non-small Cell Lung Cancer | Squamous Cell Carcinoma

China
Yonsei University

Completed

Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer

Advanced Biliary Tract Cancer

Korea, Republic of
Kessler Foundation
National Institute on Disability, Independent Living, and Rehabilitation... and other collaborators

Completed

Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury

Spinal Cord Injury

United States
Minghui Zhang
Shanghai Public Health Clinical Center; First Hospital of Tsinghua University

Recruiting

Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Non-small Cell Lung Cancer

China
Anhui Provincial Cancer Hospital
Anhui Kecheng intelligent health technology Co., LTD

Recruiting

Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

Ovarian Cancer

China
Seoul National University Hospital

Completed

MG4101 for Refractory or Relapsed AML

Acute Myeloid Leukemia

Korea, Republic of
Asan Medical Center
Korea Research Institute of Bioscience & Biotechnology

Completed

Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation (DNKI-II)

Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia

Korea, Republic of

Search clinical trials for: cytokine-induced killer cell

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations